The Societal Economic Impact of Secukinumab in First‑Line Treatment of Moderate to Severe Plaque Psoriasis in Germany: An Open‑Cohort Simulation

[featured_image]
  • Version
  • Download 2100
  • Dateigrösse 0.00 KB
  • Datei-Anzahl 1
  • Erstellungsdatum 1. January 2021
  • Zuletzt aktualisiert 13. July 2023

The Societal Economic Impact of Secukinumab in First‑Line Treatment of Moderate to Severe Plaque Psoriasis in Germany: An Open‑Cohort Simulation

Attached Files

DateiAktion
s41669-021-00305-3?sharing_token=3gOEe_yAcl_bVOPuvkZR1fe4RwlQNchNByi7wbcMAY6Ej32oAYWuq__Q1MSA1Lz4x0_HSjs8jUfaGVvZCmgdEwAivBSqkQSREdsm35ic213MI19-wG2TV_PgAyz6JIKx8exBZZMpU8gnvVfeP5PUYJ3BsmIOeya4onky4VDJl_E%253DDownload